| Financial Year |
March 31 2023 |
| Monetary Funds |
380,917,915.38 |
| Held-for-trading Financial Assets |
609,990,269.79 |
| Notes Receivable |
3,247,597.27 |
| Accounts Receivable |
204,630,603.53 |
| Advances to Suppliers |
5,065,632.16 |
| Other Receivables |
2,628,062.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
179,914,879.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,681,892.61 |
| Total Current Assets |
1,427,173,350.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
161,801,803.94 |
| Under-construction Projects |
15,632,394.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,057,223.42 |
| R&D expenses |
-- |
| Goodwill |
1,610,843.49 |
| Long-Term Deferred and Prepaid Expenses |
530,774.53 |
| Deferred Income Tax Assets |
6,652,650.51 |
| Other Non-Current Assets |
13,819,485.37 |
| Sub-Total of Non-Current Assets |
389,050,109.21 |
| Total Assets |
1,816,223,459.92 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,367,616.00 |
| Accounts Payable |
127,315,936.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,547,155.43 |
| Taxes Payable |
17,585,950.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,067,182.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,746,207.39 |
| Other Current Liabilities |
657,825.17 |
| Sub-Total of Current Liabilities |
195,649,491.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,027,677.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,496,058.97 |
| Total Liabilities |
207,145,550.47 |
| Paid-In Capital(Or Share Stock) |
229,632,000.00 |
| Capital Surplus |
115,062,600.98 |
| Surplus Reserve |
157,491,010.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,103,472,422.23 |
| Minority Stockholder's Interest |
511,495.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,608,566,413.57 |
| Owner's Equity（Stockholder's Equity） |
1,609,077,909.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,816,223,459.92 |
